Cargando…

Malonate as a ROS product is associated with pyruvate carboxylase activity in acute myeloid leukaemia cells

BACKGROUND: The role of anaplerotic nutrient entry into the Krebs cycle via pyruvate carboxylase has been the subject of increased scrutiny and in particular whether this is dysregulated in cancer. Here, we use a tracer-based NMR analysis involving high-resolution (1)H-(13)C-HSQC spectra to assess s...

Descripción completa

Detalles Bibliográficos
Autores principales: Reed, Michelle A. C., Ludwig, Christian, Bunce, Christopher M., Khanim, Farhat L., Günther, Ulrich L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972992/
https://www.ncbi.nlm.nih.gov/pubmed/27493727
http://dx.doi.org/10.1186/s40170-016-0155-7
_version_ 1782446333892755456
author Reed, Michelle A. C.
Ludwig, Christian
Bunce, Christopher M.
Khanim, Farhat L.
Günther, Ulrich L.
author_facet Reed, Michelle A. C.
Ludwig, Christian
Bunce, Christopher M.
Khanim, Farhat L.
Günther, Ulrich L.
author_sort Reed, Michelle A. C.
collection PubMed
description BACKGROUND: The role of anaplerotic nutrient entry into the Krebs cycle via pyruvate carboxylase has been the subject of increased scrutiny and in particular whether this is dysregulated in cancer. Here, we use a tracer-based NMR analysis involving high-resolution (1)H-(13)C-HSQC spectra to assess site-specific label incorporation into a range of metabolite pools, including malate, aspartate and glutamate in the acute myeloid leukaemia cell line K562. We also determine how this is affected following treatment with the redeployed drug combination of the lipid-regulating drug bezafibrate and medroxyprogesterone (BaP). RESULTS: Using the tracer-based approach, we assessed the contribution of pyruvate carboxylase (PC) vs. pyruvate dehydrogenase (PDH) activity in the derivation of Krebs cycle intermediates. Our data show that PC activity is indeed high in K562 cells. We also demonstrate a branched entry to the Krebs cycle of K562 cells with one branch running counterclockwise using PC-derived oxaloacetate and the other clockwise from the PDH activity. Finally, we show that the PC activity of K562 cells exclusively fuels the ROS-induced decarboxylation of oxaloacetate to malonate in response to BaP treatment; resulting in further Krebs cycle disruption via depletion of oxaloacetate and malonate-mediated inhibition of succinate dehydrogenase (SDH) resulting in a twofold reduction of fumarate. CONCLUSIONS: This study extends the interest in the PC activity in solid cancers to include leukaemias and further demonstrates the value of tracer-based NMR approaches in generating a more accurate picture of the flow of carbons and metabolites within the increasingly inappropriately named Krebs cycle. Moreover, our studies indicate that the PC activity in cancer cells can be exploited as an Achilles heel by using treatments, such as BaP, that elevate ROS production. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40170-016-0155-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4972992
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49729922016-08-05 Malonate as a ROS product is associated with pyruvate carboxylase activity in acute myeloid leukaemia cells Reed, Michelle A. C. Ludwig, Christian Bunce, Christopher M. Khanim, Farhat L. Günther, Ulrich L. Cancer Metab Research BACKGROUND: The role of anaplerotic nutrient entry into the Krebs cycle via pyruvate carboxylase has been the subject of increased scrutiny and in particular whether this is dysregulated in cancer. Here, we use a tracer-based NMR analysis involving high-resolution (1)H-(13)C-HSQC spectra to assess site-specific label incorporation into a range of metabolite pools, including malate, aspartate and glutamate in the acute myeloid leukaemia cell line K562. We also determine how this is affected following treatment with the redeployed drug combination of the lipid-regulating drug bezafibrate and medroxyprogesterone (BaP). RESULTS: Using the tracer-based approach, we assessed the contribution of pyruvate carboxylase (PC) vs. pyruvate dehydrogenase (PDH) activity in the derivation of Krebs cycle intermediates. Our data show that PC activity is indeed high in K562 cells. We also demonstrate a branched entry to the Krebs cycle of K562 cells with one branch running counterclockwise using PC-derived oxaloacetate and the other clockwise from the PDH activity. Finally, we show that the PC activity of K562 cells exclusively fuels the ROS-induced decarboxylation of oxaloacetate to malonate in response to BaP treatment; resulting in further Krebs cycle disruption via depletion of oxaloacetate and malonate-mediated inhibition of succinate dehydrogenase (SDH) resulting in a twofold reduction of fumarate. CONCLUSIONS: This study extends the interest in the PC activity in solid cancers to include leukaemias and further demonstrates the value of tracer-based NMR approaches in generating a more accurate picture of the flow of carbons and metabolites within the increasingly inappropriately named Krebs cycle. Moreover, our studies indicate that the PC activity in cancer cells can be exploited as an Achilles heel by using treatments, such as BaP, that elevate ROS production. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40170-016-0155-7) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-04 /pmc/articles/PMC4972992/ /pubmed/27493727 http://dx.doi.org/10.1186/s40170-016-0155-7 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Reed, Michelle A. C.
Ludwig, Christian
Bunce, Christopher M.
Khanim, Farhat L.
Günther, Ulrich L.
Malonate as a ROS product is associated with pyruvate carboxylase activity in acute myeloid leukaemia cells
title Malonate as a ROS product is associated with pyruvate carboxylase activity in acute myeloid leukaemia cells
title_full Malonate as a ROS product is associated with pyruvate carboxylase activity in acute myeloid leukaemia cells
title_fullStr Malonate as a ROS product is associated with pyruvate carboxylase activity in acute myeloid leukaemia cells
title_full_unstemmed Malonate as a ROS product is associated with pyruvate carboxylase activity in acute myeloid leukaemia cells
title_short Malonate as a ROS product is associated with pyruvate carboxylase activity in acute myeloid leukaemia cells
title_sort malonate as a ros product is associated with pyruvate carboxylase activity in acute myeloid leukaemia cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972992/
https://www.ncbi.nlm.nih.gov/pubmed/27493727
http://dx.doi.org/10.1186/s40170-016-0155-7
work_keys_str_mv AT reedmichelleac malonateasarosproductisassociatedwithpyruvatecarboxylaseactivityinacutemyeloidleukaemiacells
AT ludwigchristian malonateasarosproductisassociatedwithpyruvatecarboxylaseactivityinacutemyeloidleukaemiacells
AT buncechristopherm malonateasarosproductisassociatedwithpyruvatecarboxylaseactivityinacutemyeloidleukaemiacells
AT khanimfarhatl malonateasarosproductisassociatedwithpyruvatecarboxylaseactivityinacutemyeloidleukaemiacells
AT guntherulrichl malonateasarosproductisassociatedwithpyruvatecarboxylaseactivityinacutemyeloidleukaemiacells